|Bid||0.00 x 800|
|Ask||40.96 x 1000|
|Day's range||24.64 - 25.94|
|52-week range||13.19 - 76.10|
|Beta (5Y monthly)||1.39|
|PE ratio (TTM)||N/A|
|Earnings date||30 Aug 2022 - 05 Sept 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||30.91|
The consensus price target hints at a 25.5% upside potential for Phreesia (PHR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
RALEIGH, N.C., June 22, 2022--Patients’ expectations of healthcare technology are changing to reflect the digital conveniences they are used to in other aspects of their lives, according to research in a newly published white paper from Phreesia. Based on the results of a survey of 4,136 patients, the paper sheds light on the consumer-centric trends reshaping healthcare delivery and shares best practices that healthcare organizations can employ to improve patients’ experience and better engage t
NEWBURY PARK, Calif. & RALEIGH, N.C., June 07, 2022--Compulink Healthcare Solutions, a leader in specialty-specific all-in-one EHR solutions; and Phreesia, a leader in patient intake, outreach and activation, are pleased to announce that they have partnered to offer a robust, bidirectional integration between their systems. This integration will help practices save time, increase patient collections, improve patient satisfaction, and keep their schedules full.